Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Study reveals underrepresentation of women in cardiovascular clinical trials

Study reveals underrepresentation of women in cardiovascular clinical trials

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

Animal study shows calcineurin enzyme is critical for normal heart function

Animal study shows calcineurin enzyme is critical for normal heart function

New book explores economic, demographic and cultural aspects that threaten healthcare and AMCs

New book explores economic, demographic and cultural aspects that threaten healthcare and AMCs

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Blood transfusions based on single low hematocrit measurement questioned

Blood transfusions based on single low hematocrit measurement questioned

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Pediatric patients face number of cardiac conditions that can impact their health

Pediatric patients face number of cardiac conditions that can impact their health

Low RVEF increases risk of death in patients with systolic heart failure

Low RVEF increases risk of death in patients with systolic heart failure

Picis launches LYNX CareBridge software to help hospitals address medical necessity challenges

Picis launches LYNX CareBridge software to help hospitals address medical necessity challenges

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

Right-ventricular impairment increases risk of death in heart-failure patients

Right-ventricular impairment increases risk of death in heart-failure patients

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

Special issue reviews current state of science in fetal therapy

Special issue reviews current state of science in fetal therapy

UCSF researchers: B1N1 protein is necessary for heart to contract

UCSF researchers: B1N1 protein is necessary for heart to contract

Discharged VAD implanted pediatric patient receives successful heart transplant after eight months

Discharged VAD implanted pediatric patient receives successful heart transplant after eight months

Traditional Home Health and Hospice selects ExpressMD's Electronic House Call system for CHF program

Traditional Home Health and Hospice selects ExpressMD's Electronic House Call system for CHF program

Chemical compound found in blood shows promise in preventing intractable form of heart failure

Chemical compound found in blood shows promise in preventing intractable form of heart failure

NovaShunt initiates study to evaluate AFS for refractory ascites patients

NovaShunt initiates study to evaluate AFS for refractory ascites patients

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.